drugs that target glp 1 GLP-1 Medications for Weight Loss Study finds GLP-1 receptor agonists

Recent studies have found that increased level of GLP-1 in the hippocampus restores GABA and reverses this neurotoxic effect by reducing oxidative stress through the SIRT1/Nrf2/HO-1 pathway, promoting autophagy through the AMPK/mTOR pathway, and alleviating hippocampal apoptosis by inactivating pro-apoptotic kinase GSK-3 ( The anorectic effects of GLP-1 can also be explained by its GABAergic modulation in the nucleus tractus solitarius (NTS) cells

[DOI] [PubMed] [Google Scholar] Nuako A, Tu L

432 The research was a 14-month Phase II double-blind randomized controlled trial

We focus on combining medication therapy with healthy nutrition and regular exercise to achieve the best results

CAUTION: Consult your physician before use if you are pregnant or nursing, taking medications, undergoing laboratory tests, or have a health condition

To qualify, you generally need: A BMI of 30 or higher, or 27 or higher with a weight-related condition A prior trial of an oral weight-loss medication such as Qsymia or Contrave that did not work or that you cannot take At least 6 months of attempted weight loss through diet and exercise A prior authorization from your prescriber documenting medical necessity For type 2 diabetes, TRICARE coverage of GLP-1s like Ozempic and Mounjaro is more straightforward, though prior authorization may still apply